Form 4 | Kodiak Sciences directors and 10% owners Felix Baker and Julian Baker, via funds, purchased ~359,000 common shares (P).
Filings Track
Yesterday
In this Form 4 filing, Felix J. Baker and Julian C. Baker, directors and 10% owners of Kodiak Sciences Inc. (KOD), reported multiple open-market purchases of common stock executed via their funds 667, L.P. and Baker Brothers Life Sciences LP on September 28–29, 2026. Individual trades ranged from hundreds of shares to nearly 200,000 shares, at weighted-average prices broadly between $84 and $90, totaling approximately 359,000 shares acquired. Following these transactions, the funds collectively own about 20.19 million shares, reinforcing their position as major shareholders. Such sizeable and continued buying by key shareholders generally signals confidence in the company’s long-term prospects and can be interpreted as a supportive, mildly bullish factor for the stock, though investors should still weigh fundamentals, valuation, and sector risks.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.